Year: 2022

Quality Gold, Inc. Announces Filing of Registration Statement on Form S-4 in Connection with Its Proposed Business Combination with Tastemaker Acquisition Corp.

Written by Customer Service on December 23, 2022. Posted in Mergers And Acquisitions.

Quality Gold to Participate in the 25th Annual ICR Conference FAIRFIELD, Ohio and NEW YORK, Dec. 23, 2022 (GLOBE NEWSWIRE) — Quality Gold, Inc. and certain of its affiliates and subsidiaries (“Quality Gold” or the “Company”), a leading vertically integrated specialty logistics and jewelry distributor, and Tastemaker Acquisition Corp. (Nasdaq: TMKR) (“TMKR” or “Tastemaker”), a publicly traded special purpose acquisition company, announces the filing by Quality Gold Holdings, Inc. (“New Parent”) of a registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) relating to the previously announced proposed business combination of Quality Gold and Tastemaker (the “Proposed Business Combination”). The Registration Statement includes a preliminary prospectus with...

CytoDyn to Hold Webcast to Discuss the Performance of Leronlimab in Clinical Trials and Recent Charges Against Former CEO

Written by Customer Service on December 23, 2022. Posted in Public Companies.

VANCOUVER, Washington, Dec. 23, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, will hold a webcast on December 29, 2022 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss the performance of leronlimab in its clinical trials and the recent charges against its former CEO Nader Pourhassan, who was previously terminated on January 24, 2022, and has had no affiliation with the Company since that time. Webcast Access InformationDate: Thursday, December 29, 2022Time: 8:00 a.m. Pacific Time / 11:00 a.m. Eastern TimeAccess: https://event.choruscall.com/mediaframe/webcast.html?webcastid=i2RX9JZGThe replay will be available approximately...

Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis due to NASH

Written by Customer Service on December 23, 2022. Posted in Public Companies.

NDA supported by robust NASH clinical development program, including two positive interim analyses from the Phase 3 REGENERATE study NDA includes detailed safety analysis of 2,477 patients with nearly 1,000 patients on study drug for 4 years MORRISTOWN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it has resubmitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for obeticholic acid (OCA) for the treatment of patients with pre-cirrhotic liver fibrosis due to nonalcoholic steatohepatitis (NASH). The resubmission is supported by a robust body of evidence from the OCA NASH clinical development program,...

Eimskip’s Financial Calendar 2023

Written by Customer Service on December 23, 2022. Posted in Public Companies.

Fourth quarter 2022 14 February 2023 Annual General Meeting 2023 9 March 2023 First quarter 2023 11 May 2023 Second quarter 2023 17 August 2023 Third quarter 2023 2 November 2023 Fourth quarter 2023 8 February 2024 Annual General Meeting 2024 7 March 2024 Financial results will be disclosed and published after market closing. Please note that dates are subject to change.

atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101

Written by Customer Service on December 23, 2022. Posted in Public Companies.

– This two-part phase 1 trial in healthy volunteers was designed to assess the safety, pharmacokinetics, and analgesic activity of KUR-101 – KUR-101 was well tolerated and demonstrated analgesic activity in two experimental pain models – An assessment of the respiratory impact of KUR-101 was inconclusive as the positive control, oxycodone, failed to separate from placebo – KUR-101, a deuterated derivative of mitragynine, is a low-potency, partial mu-opioid receptor (MOR) agonist designed to produce therapeutic effects without clinically significant respiratory depression NEW YORK and BERLIN, Dec. 23, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai” or “the Company”), a clinical stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today...

Form 8.3 – [Devro plc – 22 12 2022] – (CGWL)

Written by Customer Service on December 23, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree DEVRO PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Iris Energy’s 160MW of Data Center Capacity in British Columbia Not Affected by Recent Government Decision to Temporarily Suspend New and Early Stage Connection Requests for Cryptocurrency Mining

Written by Customer Service on December 23, 2022. Posted in Public Companies.

SYDNEY, Australia, Dec. 23, 2022 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (“Iris Energy” or “the Company”), a leading owner and operator of institutional-grade, highly efficient Bitcoin mining data centers powered by 100% renewable energy, today announced that its 160MW of data center capacity is not affected by the recent announcement by the Government of British Columbia. On December 21, 2022, the Government of British Columbia announced a temporary 18-month suspension on new and early stage BC Hydro connection requests from cryptocurrency mining projects due to unprecedented interest1. According to the release, cryptocurrency mining projects that are operational, and a small number of projects that are well advanced in BC Hydro’s connection process, will not be affected. As a result, the Company’s 160MW of data...

European Energy A/S: Financial Calendar 2023

Written by Customer Service on December 23, 2022. Posted in Public Companies.

Company announcement 18/2022 (23.12.2022) The Board of Directors of European Energy A/S has set the dates for the release of the Annual Report, interim reports as well as the Annual General Meeting in 2023. Please see attached the Financial Calendar for 2023. For further information, please contact Investor Relations, investor.relations@europeanenergy.comAttachmentFinancial Calendar 2023

Correction: Financial reporting calendar for the year 2023

Written by Customer Service on December 23, 2022. Posted in Public Companies.

In the Estonian announcement, information about the financial results to be published on 28.04.2023 has been corrected. On 28.04.2023 the audited annual report for 2022 will be published, not the unaudited 2022 annual report. AS Baltika publishes the consolidated financial results as follows:28.02.2023 Unaudited interim report for the IV quarter28.04.2023 Audited annual report for 202231.05.2023 Unaudited interim report for the I quarter31.08.2023 Unaudited interim report for the II quarter30.11.2023 Unaudited interim report for the III quarterThe financial results will be announced in Estonian and English on the dates listed above at 8:00 a.m. local Eastern European Time (EET). The 2022 annual general meeting of shareholders will be held in the second quarter of 2023, the exact time and location will be...

Kalmar and Uwe Kleinwort strengthen long term collaboration with a large new order for Gloria reachstackers

Written by Customer Service on December 23, 2022. Posted in Public Companies.

Kalmar Reachstacker DRG450 Gloria Kalmar Reachstacker DRG450 GloriaKalmar Reachstacker DRG450 Gloria Kalmar Reachstacker DRG450 GloriaCARGOTEC CORPORATION, PRESS RELEASE, 23 DECEMBER 2022 AT 10 AM (EET) Kalmar, part of Cargotec, has concluded an agreement with Uwe Kleinwort GmbH to supply six Kalmar Gloria reachstackers with a lifting capacity of 45 tons. The order was booked in Cargotec’s Q4 2022 order intake, with delivery scheduled for Q2 of 2023. Located in the Port of Hamburg in northern Germany, Uwe Kleinwort GmbH is nationally recognised for its quality services and high productivity. The company’s extensive rental equipment fleet includes Kalmar reachstackers, terminal tractors, forklift trucks and empty container handlers. This latest order follows an order of six Kalmar Gloria reachstackers and six medium forklift trucks ...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals